S2 Ep7: Pharmacy Focus: Policy Editions - February 2024 Rx Roundup
Pharmacy Focus15 Feb 2024

S2 Ep7: Pharmacy Focus: Policy Editions - February 2024 Rx Roundup

In this episode, we discuss 3 new pharmacy policies and initiatives across the United States as part of a new "RX rundown" format. First, California enacted the Stop Dangerous Pharmacies Act to improve patient safety through mandatory error reporting, minimum staffing, and expanded technician roles. Then, E-prescribing was discussed as a way to enhance accuracy, safety, and reduce costs and errors, though national standards and privacy issues present challenges. Lastly, New Jersey is piloting anonymous dispensing of opioid antidotes from pharmacies under standing orders from health officials to help address the opioid crisis, with pharmacist education requirements.

Key Takeaways:
1. California enacted the Stop Dangerous Pharmacies Act to mandate medication error reporting, minimum staffing requirements, and expand pharmacy technician roles like administering vaccines.
2. E-prescribing can improve accuracy, safety, and reduce costs by reducing errors and combating forged prescriptions while improving pharmacy workflow. However, it faces challenges around national standards and security/privacy.
3. New Jersey launched a pilot program allowing anonymous dispensing of opioid antidotes from pharmacies with standing orders from health officials, and pharmacists must provide overdose prevention education.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(356)

S2 Ep93: Vaccine Timing and Safety in Patients With Neurological Diseases

S2 Ep93: Vaccine Timing and Safety in Patients With Neurological Diseases

This episode of Mind the Meds features guest Patti Yager-Stone, PharmD, BCPS, a clinical pharmacist in neurology at the Veterans Affairs Medical Center in Portland, Oregon, who oversees infusion manag...

3 Sep 50min

S2 Ep92: Beyond CRS and ICANS: Managing the Delayed Toxicities of Cilta-cel

S2 Ep92: Beyond CRS and ICANS: Managing the Delayed Toxicities of Cilta-cel

Sara Scott, PharmD, BCOP, Emma Uchida, PharmD, MBA, BCOP, and Rebecca Gonzalez, PharmD, BCOP, gather for a roundtable on the rare, delayed toxicities associated with ciltacabtagene autoleucel in relap...

28 Aug 50min

S2 Ep91: Food, Fungals, and Flexibility: Real-World Dosing of Revumenib

S2 Ep91: Food, Fungals, and Flexibility: Real-World Dosing of Revumenib

26 Aug 25min

S2 Ep90: Introducing the Psychiatric Pharmacist Pulse Podcast

S2 Ep90: Introducing the Psychiatric Pharmacist Pulse Podcast

Megan Maroney, PharmD, BCPP, FAAPP: Hello, I'm Megan Maroney, and this is Psychiatric Pharmacy Pulse, a monthly podcast where we talk about hot topics in psychiatric pharmacy. I'm a clinical associate...

21 Aug 1min

S2 Ep89: Under the Skin: What Subcutaneous Isatuximab Means for Myeloma Care

S2 Ep89: Under the Skin: What Subcutaneous Isatuximab Means for Myeloma Care

Matthew Lei, PharmD, BCOP, a clinical oncology pharmacist at Massachusetts General Hospital, joins Pharmacy Focus: Oncology Edition to break down the FDA approval of subcutaneous isatuximab-irfc via t...

20 Aug 31min

S2 Ep88: CMSC 2026 Highlights: Biomarkers, DMT Discontinuation, and Pregnancy Planning in MS

S2 Ep88: CMSC 2026 Highlights: Biomarkers, DMT Discontinuation, and Pregnancy Planning in MS

In this episode of Mind the Meds, host Erica Marini, PharmD, MS, BCPS, welcomes Jenelle Hall Montgomery, PharmD, BCACP, CPP, a clinical pharmacist practitioner with Duke Neurological Disorders Clinic ...

6 Aug 54min

S2 Ep86: Untangling Holistic, Integrative, Functional, and Precision Medicine in Oncology

S2 Ep86: Untangling Holistic, Integrative, Functional, and Precision Medicine in Oncology

Holistic, integrative, functional, precision—the labels are everywhere, but few patients or clinicians know where one ends and the next begins.

24 Juli 37min

S2 Ep84: Beyond Seizures: Phenobarbital's Clinically Significant Interaction Profile

S2 Ep84: Beyond Seizures: Phenobarbital's Clinically Significant Interaction Profile

To open the episode, Erica Marini, PharmD, discussed a roundup of FDA and research updates in neurology. She covered the shifting accelerated-approval pathway for AMT-130 (uniQure), a gene therapy for...

2 Juli 53min

Populärt inom Hälsa

somna-med-henrik
rss-jossan-nina
rss-bara-en-till-om-beroende-medberoende
inga-beiga-morsor
bullfika
rss-vuxna-pa-latsas
not-fanny-anymore
johannes-hansen-podcast
rss-viktmedicinpodden
sexnoveller-deluxe
angestpodden
sa-in-i-sjalen
rss-hos-psykologen
rss-angra-inget-3
sova-med-dan-horning
rss-basta-livet
rss-autismandan
tyngre-radio
rss-ronden
tyngre-traningssnack